Astal Laboratories Ltd — Others, 18-08-2025: Others

Astal Laboratories has released its annual financial results for the year: revenue surged 171.64% to Rs. 64.35 Cr, and profit after tax jumped 1039.20% to Rs. 8.92 Cr (Rs. 9.08 EPS). The company, which acquired a pharmaceutical intermediates plant, plans to retain surplus for working capital instead of declaring a dividend. The upcoming 32nd Annual General Meeting will seek shareholder approval for re-appointing a director, confirming auditors, and significantly expanding borrowing, loan, and investment capacities up to Rs. 500 Cr each to fuel future business growth, particularly in API production.